Related references
Note: Only part of the references are listed.FRAX-based intervention and assessment thresholds in seven Latin American countries
P. Clark et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip FracturesA Post Hoc Analysis of the SCOOP Study
Eugene McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry
William D. Leslie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study
David A. Turner et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial
Lee Shepstone et al.
LANCET (2018)
Correcting the Record on a Fracture Risk Assessment Tool
Laragh Gollogly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models
H. Ramanau et al.
ARCHIVES OF OSTEOPOROSIS (2018)
The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
FRAX-vs. T-score-based intervention thresholds for osteoporosis
H. Johansson et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate
O. Lesnyak et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil
Dalisbor Marcelo Weber Silva et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Epidemiology of hip fracture and the development of FRAX in Ukraine
V. V. Povoroznyuk et al.
ARCHIVES OF OSTEOPOROSIS (2017)
UK clinical guideline for the prevention and treatment of osteoporosis
J. Compston et al.
ARCHIVES OF OSTEOPOROSIS (2017)
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Clarifying WHO's position on the FRAX® tool for fracture prediction
Nathan Ford et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2016)
Adjusting Hip Fracture Probability in Men and Women Using Hip Axis Length: the Manitoba Bone Density Database
William D. Leslie et al.
JOURNAL OF CLINICAL DENSITOMETRY (2016)
CHRISTMAS 2016 Evidence, expertise, and facts in a post-truth society
Tracey Brown
BMJ-BRITISH MEDICAL JOURNAL (2016)
CHRISTMAS 2016 Evidence, expertise, and facts in a post-truth society
Tracey Brown
BMJ-BRITISH MEDICAL JOURNAL (2016)
A systematic review of intervention thresholds based on FRAX A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation
John A. Kanis et al.
ARCHIVES OF OSTEOPOROSIS (2016)
The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis
Andrea Marques et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Adjusting Fracture Probability by Trabecular Bone Score
Eugene V. McCloskey et al.
CALCIFIED TISSUE INTERNATIONAL (2015)
Intervention Thresholds and the Diagnosis of Osteoporosis
John A. Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Osteoporosis: the emperor has no clothes
T. L. N. Jarvinen et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Burden of high fracture probability worldwide: secular increases 2010-2040
A. Oden et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Is the Swedish FRAX model appropriate for Swedish immigrants?
H. Johansson et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Overdiagnosis of osteoporosis: fact or fallacy?
J. Compston
OSTEOPOROSIS INTERNATIONAL (2015)
Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis
E. V. McCloskey et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX
N. C. Harvey et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density
S. Nayak et al.
OSTEOPOROSIS INTERNATIONAL (2015)
TOO MUCH MEDICINE Overdiagnosis of bone fragility in the quest to prevent hip fracture
Teppo L. N. Jarvinen et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
TOO MUCH MEDICINE Overdiagnosis of bone fragility in the quest to prevent hip fracture
Teppo L. N. Jarvinen et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Incidence of hip fracture in Brazil and the development of a FRAX model
C. A. F. Zerbini et al.
ARCHIVES OF OSTEOPOROSIS (2015)
Evaluation of the FRAX Model for Hip Fracture Predictions in the Population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE)
Reijo Sund et al.
CALCIFIED TISSUE INTERNATIONAL (2014)
Impact of Femoral Neck and Lumbar Spine BMD Discordances on FRAX Probabilities in Women: A Meta-analysis of International Cohorts
H. Johansson et al.
CALCIFIED TISSUE INTERNATIONAL (2014)
Conflicts at the heart of the FRAX tool
Teppo L. N. Jarvinen et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2014)
Major Osteoporotic to Hip Fracture Ratios in Canadian Men and Women With Swedish Comparisons: A Population-Based Analysis
Anna Lam et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures
H. Johansson et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Comparison between various fracture risk assessment tools
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2014)
The incidence of a first major osteoporotic fracture in Iceland and implications for FRAX
K. Siggeirsdottir et al.
OSTEOPOROSIS INTERNATIONAL (2014)
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
E. S. Siris et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Lumbar spine texture enhances 10-year fracture probability assessment
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Incidence of Hip Fracture in Romania and the Development of a Romanian FRAX Model
Daniel Grigorie et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Incidence of Hip Fracture in Barranquilla, Colombia, and the Development of a Colombian FRAX Model
J. J. Jaller-Raad et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Intervention thresholds for denosumab in the UK using a FRAXA®-based cost-effectiveness analysis
O. Strom et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Updated fracture incidence rates for the Italian version of FRAX®
P. Piscitelli et al.
OSTEOPOROSIS INTERNATIONAL (2013)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Development and application of FRAX in the management of osteoporosis in Ireland
B. McGowan et al.
ARCHIVES OF OSTEOPOROSIS (2013)
FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort
Rafael Azagra et al.
BMC MUSCULOSKELETAL DISORDERS (2012)
FRAX(A (R)) with and without Bone Mineral Density
John A. Kanis et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Hip Fracture Incidence from 1981 to 2009 in the Czech Republic as a Basis of the Country-Specific FRAX Model
Jan J. Stepan et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: The fracture intervention trial
Meghan G. Donaldson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Type 2 Diabetes and Bone
William D. Leslie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
FRAX underestimates fracture risk in patients with diabetes
Lora M. Giangregorio et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis
B. Jonsson et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study
S. Tuzun et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures
A. Lalmohamed et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Pitfalls in the external validation of FRAX
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2012)
The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study
Sansin Tuzun et al.
Archives of Osteoporosis (2012)
Epidemiology of fracture in the Russian Federation and the development of a FRAX model
Olga Lesnyak et al.
Archives of Osteoporosis (2012)
WHO Absolute Fracture Risk Models (FRAX): Do Clinical Risk Factors Improve Fracture Prediction in Older Women Without Osteoporosis?
Teresa A. Hillier et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Evaluation of the FRAX and Garvan Fracture Risk Calculators in Older Women
Mark J. Bolland et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®
Didier B. Hans et al.
JOURNAL OF CLINICAL DENSITOMETRY (2011)
Official Positions for FRAX® Clinical Regarding Falls and Frailty: Can Falls and Frailty be Used in FRAX®?
Tahir Masud et al.
JOURNAL OF CLINICAL DENSITOMETRY (2011)
Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance
A. C. Looker et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Evaluation of FRAX to characterise fracture risk in Poland
E. Czerwinski et al.
OSTEOPOROSIS INTERNATIONAL (2011)
A FRAXA® model for the assessment of fracture probability in Belgium
H. Johansson et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Construction of a FRAXA® model for the assessment of fracture probability in Canada and implications for treatment
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
B. Jonsson et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Erratum to: A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Guidance for the adjustment of FRAX according to the dose of glucocorticoids
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Interpretation and use of FRAX in clinical practice
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility
W. Pluskiewicz et al.
BONE (2010)
FRAX® and its applications in health economics-Cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example
O. Strom et al.
BONE (2010)
A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRA®
John A. Kanis et al.
BONE (2010)
The diagnosis of osteoporosis
John A. Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
The FRAX Tool in French Women: How Well Does It Describe the Real Incidence of Fracture in the OFELY Cohort
Elisabeth Sornay-Rendu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Fracture Risk Prediction Using BMD and Clinical Risk Factors in Early Postmenopausal Women: Sensitivity of the WHO FRAX Tool
Florence A. Tremollieres et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
FRAXA® assessment of osteoporotic fracture probability in Switzerland
K. Lippuner et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Updated fracture incidence rates for the US version of FRAXA (R)
B. Ettinger et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Prognosis of fracture: evaluation of predictive accuracy of the FRAX™ algorithm and Garvan nomogram
S. K. Sandhu et al.
OSTEOPOROSIS INTERNATIONAL (2010)
The potential impact of new National Osteoporosis Foundation guidance on treatment patterns
B. Dawson-Hughes et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Setting a standard for a silent'' disease: defining osteoporosis in the 1980s and 1990s
Caitlin Donahue Wylie
STUDIES IN HISTORY AND PHILOSOPHY OF SCIENCE PART C-STUDIES IN HISTORY AND PHILOSOPHY OF BIOLOGICAL AND BIOMEDIAL SCIENCES (2010)
Predicting Risk of Osteoporotic Fracture in Men and Women in England and Wales: Prospective Derivation and Validation of QFractureScores
P. Mikosch
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
A Comparison of Prediction Models for Fractures in Older Women Is More Better?
Kristine E. Ensrud et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®
John A. Kanis et al.
BONE (2009)
FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial
Meghan G. Donaldson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Vertebral Fracture Status and the World Health Organization Risk Factors for Predicting Osteoporotic Fracture Risk
Peiqi Chen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
J. Compston et al.
MATURITAS (2009)
Incorporating adherence into health economic modelling of osteoporosis
O. Strom et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomised study
E. V. McCloskey et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women
K. Lippuner et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Ten-year fracture probability in Hong Kong Southern Chinese according to age and BMD femoral neck T-scores
S. W. Y. Tsang et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
The cost-effectiveness of alendronate in the management of osteoporosis
John A. Kanis et al.
BONE (2008)
A reference standard for the description of osteoporosis
John A. Kanis et al.
BONE (2008)
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)
S. Fujiwara et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Cost-effective osteoporosis treatment thresholds: the United States perspective
A. N. A. Tosteson et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Case finding for the management of osteoporosis with FRAX® -: assessment and intervention thresholds for the UK
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden
N. Zethraeus et al.
OSTEOPOROSIS INTERNATIONAL (2008)
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Cost-effectiveness of the treatment and prevention of osteoporosis - a review of the literature and a reference model
N. Zethraeus et al.
OSTEOPOROSIS INTERNATIONAL (2007)
An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting -: Based on the results of the SOTI and TROPOS trials
F. Borgstrom et al.
OSTEOPOROSIS INTERNATIONAL (2006)
At what hip fracture risk is it cost-effective to treat?: International intervention thresholds for the treatment of osteoporosis
F. Borgstroem et al.
OSTEOPOROSIS INTERNATIONAL (2006)
The cost-effectiveness of risedronate in the treatment of osteoporosis:: an international perspective
F. Borgstrom et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors
C Roux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Incidence rates and life-time risk of hip fractures in Mexicans over 50 years of age:: a population-based study
P Clark et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Body mass index as a predictor of fracture risk:: A meta-analysis
C De Laet et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Ten-year probabilities of clinical vertebral fractures according to phalangeal quantitative ultrasonography
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden:: Results based on the Women's Health Initiative randomized controlled trial
N Zethraeus et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2005)
Alcohol intake as a risk factor for fracture
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
A meta-analysis of milk intake and fracture risk: low utility for case finding
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Predictive value of BMD for hip and other fractures
O Johnell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Assessment of fracture risk
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Requirements for DXA for the management of osteoporosis in Europe
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
The impact of the use of multiple risk indicators for fracture on case-finding strategies:: a mathematical approach
C De Laet et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Smoking and fracture risk: a meta-analysis
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Intervention thresholds for osteoporosis in the UK
JA Kanis et al.
BONE (2005)
Associations between baseline risk factors and vertebral fracture risk in the multiple outcomes of raloxifene evaluation (MORE) study
O Johnell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures:: the PERF study
YZ Bagger et al.
BONE (2004)
Excess mortality after hospitalisation for vertebral fracture
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2004)
A meta-analysis of previous fracture and subsequent fracture risk
JA Kanis et al.
BONE (2004)
Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden
F Borgström et al.
BONE (2004)
Mortality after osteoporotic fractures
O Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2004)
The risk and burden of vertebral fractures in Sweden
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2004)
A family history of fracture and fracture risk: a meta-analysis
JA Kanis et al.
BONE (2004)
Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2004)
A meta-analysis of prior corticosteroid use and fracture risk
JA Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Optimization of BMD measurements to identify high risk groups for treatment - A test analysis
H Johansson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden - An economic evaluation based on the MORE study
F Borgstrom et al.
PHARMACOECONOMICS (2004)
Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis:: Results of a double-blind, placebo-controlled 3-year study
E McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial
JA Kanis et al.
BONE (2003)
The components of excess mortality after hip fracture
JA Kanis et al.
BONE (2003)
The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis
R Marcus et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Cost effectiveness of alendronate (Fosamax (R)) for the treatment of osteoporosis and prevention of fractures
O Johnell et al.
PHARMACOECONOMICS (2003)
Intervention thresholds for osteoporosis
JA Kanis et al.
BONE (2002)
International variations in hip fracture probabilities: Implications for risk assessment
JA Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies
JA Kanis et al.
BONE (2002)
Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis
N Zethraeus et al.
OSTEOPOROSIS INTERNATIONAL (2002)
A new approach to the development of assessment guidelines for osteoporosis
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Acute and long-term increase in fracture risk after hospitalization for stroke
J Kanis et al.
STROKE (2001)
Effect of risedronate on the risk of hip fracture in elderly women
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Cost-effectiveness of preventing hip fracture in the general female population
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2001)
The burden of osteoporotic fractures: A method for setting intervention thresholds
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis
JA Kanis et al.
BONE (2000)
Use of oral corticosteroids and risk of fractures
TP Van Staa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Prediction of fracture from low bone mineral density measurements overestimates risk
JA Kanis et al.
BONE (2000)
Risk of hip fracture derived from relative risks: An analysis applied to the population of Sweden
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Long-term risk of osteoporotic fracture in Malmo
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Share Paper
